-- Overview of digiMedical's proprietary Microsoft-based, HIPAA compliant
digital prescription technology
-- digiMedical digital prescription technology meets Drug Enforcement
Administration (DEA) regulations to aide in the control of Schedule II
prescription drug abuse
-- Overview of digiMedical's five Company-owned pharmacies in Florida and
Texas
-- The evolvement of the pharmacy industry and the need for digital
prescription technology, reducing human error, injury to patients and
fraudulent prescriptions
-- digiReAuth, the Company's proprietary prescription re-authorization
technology allowing patients to refill prescriptions through digiMedical's
call center
-- 2008 growth and beyond, including the continued acquisition of
independent pharmacy chains and possible expansion into Latin American
markets
-- Expansion of current physician-base, gaining hundreds of patients with
each new doctor and simultaneously realizing notable increases in
prescription reauthorizations through digiMedical's call center
-- Current efforts to make the digiRX line Microsoft certified, making it
a more widely recognized technology
-- Recent additions to the board of directors with experience that will
help the Company transition off of the OTC to become a fully-reporting
OTCBB listed company
The interview is available at www.twst.com. For help viewing the article,
please contact ir@digimedical.com.
Corporate Fact Sheet and Email Updates
To receive a copy of the Company's corporate fact sheet, or future
corporate updates via email, please send an email to ir@digimedical.com.
About digiMedical Solutions, Inc.™
digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy
and medical technology company focused on developing next generation
digital medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'™ unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's filings
with the U.S. Securities and Exchange Commission for additional information
and a presentation of the risks and uncertainties that may affect the
company's business and results of operations.
Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029